Cullinan Therapeutics

About Cullinan Therapeutics

Cullinan Therapeutics is focused on creating new standards of care for patients through modality-agnostic targeted therapeutics. Their mission prioritizes patient benefit, leveraging a deep understanding of oncology, immunology, and translational medicine to develop transformative therapeutics for cancer and autoimmune indications.

Products & Services

Deep and Diversified Pipeline:A unique research and development approach identifying high-impact targets and pursuing the best modality, resulting in a diverse pipeline for various indications.

Transformative Therapeutics:Innovative therapies across cancer and autoimmune indications, developed by selecting optimal modalities and targets.

Specialties

Oncology Immunology Translational Medicine Cancer Therapeutics Autoimmune Therapeutics

Funding History

No funding data available

This company may be bootstrapped or privately funded

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Kavya Rakhra

Senior Director, Preclinical Research and Development

K

Kerry Whalen

Senior Director, Program Management

N

Nadim Ahmed

President and Chief Executive Officer

S

Steve Andre

Chief Human Resources Officer

M

Mary Kay Fenton

Chief Financial Officer

K

Kevin A. Johnston

Chief Technical Operations Officer

View 23 more team members with Pro

Unlock Full Team Directory

Recent News